Book a demo Book a demo
Aesthetic Clinic

Profhilo Injection Protocol: The Complete Clinical Guide to the BAP Technique

Luca R
February 9, 2026
Reviewed by: Avatar photo Lucy Galloway
Key Takeaways

Key Takeaways

The BAP technique uses just 10 injection points (5 per side) compared to 40+ with traditional skin boosters

Each BAP point receives 0.2ml of Profhilo in the deep dermis (intradermal placement) using a 29G needle

Standard protocol requires 2 sessions 4 weeks apart; the IBSA Instructions for Use specify maintenance every 2 months, while current consensus clinical practice supports maintenance every 6-9 months depending on patient response

The five key injection points are: zygomatic protrusion, nasal base, tragus, chin, and mandibular angle

Aspiration before injection and proper depth control are critical for patient safety

Mastering the Profhilo injection protocol is essential for aesthetic practitioners delivering Bio Aesthetic Points (BAP) treatments. This comprehensive Profhilo injection protocol guide covers the standardised technique developed by IBSA Derma, ensuring safe and effective administration of this revolutionary skin bioremodelling treatment.

This Profhilo injection protocol provides aesthetic practitioners with evidence-based guidelines covering the five key BAP injection points, proper technique, treatment schedules, and clinical safety protocols.

Clinical disclaimer: This protocol is intended for licensed and appropriately trained medical professionals. It is provided for educational reference only and does not replace formal training, supervision, or product-specific certification. All injection decisions – including patient selection, depth, dose, technique, and scheduling – should defer to the current IBSA Instructions for Use supplied with the product, to applicable regulatory guidance in the practitioner’s jurisdiction, and to the practitioner’s own clinical judgement.

Understanding the Profhilo Injection Protocol: BAP Technique Fundamentals

The Bio Aesthetic Points (BAP) technique is a standardised injection protocol developed specifically for Profhilo administration. IBSA Derma designed this method to maximise the product's unique diffusion properties whilst minimising patient discomfort and treatment time.

Traditional HA skin boosters require 40 or more injection points across the face. The BAP technique achieves superior results with just 10 strategic points (5 per side). This reduction is possible because of Profhilo's hybrid cooperative complex structure, which allows the product to spread naturally through the tissue planes.

The technique was developed with three core objectives:

  1. Optimise diffusion – Strategic placement in areas with high tissue mobility ensures even distribution across the treatment zone
  2. Minimise risk – BAP points are located in safe zones, away from major vessels and nerves
  3. Reduce discomfort – Fewer injection points mean less trauma and faster treatment sessions
Profhilo injection protocol comparison chart showing BAP technique 10 points vs standard 40+ injection points
Profhilo BAP Technique Comparison – Source: Pabau

The chart above illustrates the efficiency advantage of the BAP technique. By reducing injection points by 75%, practitioners can deliver treatments faster whilst patients experience significantly less discomfort.

The 5 Key Injection Points Breakdown (Per Side)

The Profhilo injection protocol requires precise identification of anatomical landmarks for each BAP point. Each of the five points per side has been selected for optimal safety and diffusion.

1. Zygomatic Protrusion

Location: The most prominent point of the zygomatic arch, typically 1-2cm lateral to the lateral canthus.

Landmark identification: Ask the patient to clench their teeth. Palpate along the zygomatic arch to locate the highest point of the bone. This point sits above the masseter muscle insertion.

Clinical note: This is the most superior BAP point and initiates upward diffusion across the mid-face.

2. Nasal Base

Location: On the mid-cheek, at the intersection of two reference lines defined in the IBSA BAP protocol.

Landmark identification: Draw a horizontal line from the nostril (alar base) across to the tragus, and a vertical line dropped from the pupil. The injection point sits where these two lines intersect, on the mid-cheek.

Clinical note: This point treats the mid-face area and supports diffusion towards the perioral region.

3. Tragus

Location: At least 1cm anterior to the inferior margin of the tragus.

Landmark identification: Place your finger on the inferior margin of the tragus and move downward and forward (anteriorly) at least 1cm into the soft tissue of the cheek. Do not move upward from the tragus, as this direction approaches the superficial temporal artery and the auriculotemporal nerve.

Clinical note: This point ensures lateral face coverage and jawline enhancement.

4. Chin

Location: Central chin, approximately 1cm above the inferior border of the mandible.

Landmark identification: Midline of the chin, in the soft tissue between the mentalis muscle and bone. Avoid the mental foramen, which sits more laterally.

Clinical note: This is the only midline BAP point and supports lower face diffusion.

5. Mandibular Angle

Location: At the angle of the mandible, approximately 1-2cm superior to the bone's inferior edge.

Landmark identification: Ask the patient to clench their teeth. Palpate the angle where the mandible turns from the ramus to the body. The injection point sits just above this landmark.

Clinical note: This point provides jawline definition and ensures even distribution to the lower third of the face.

Pro Tip

Mark all 10 BAP points with a surgical marker before beginning injections. This ensures symmetry and allows you to verify placement with the patient upright before they recline for treatment.

“The BAP technique transformed our Profhilo treatments completely. We’ve reduced appointment times by 40% whilst improving results. Our clients experience minimal discomfort, and we’ve had zero complications since implementing the standardised protocol. Documenting the injection points in Pabau’s client records gives us complete treatment traceability.”

Camille Armstrong
Camille Armstrong
Founder / Co-Owner, Secret Enhancements

Profhilo Injection Protocol Schedule: Treatment Timeline and Maintenance

The standard Profhilo injection protocol follows a specific evidence-based timeline designed to optimise tissue remodelling and collagen stimulation.

Initial Phase: Building the Foundation

The initial treatment course consists of two sessions, four weeks apart.

Session 1 (Week 0):

  • Administer 2ml Profhilo (one syringe)
  • Inject 0.2ml at each of the 10 BAP points
  • Total treatment time: 10-15 minutes

Session 2 (Week 4):

  • Repeat the identical protocol
  • Same dose, same points
  • The second session reinforces the bioremodelling effect initiated in session one

The four-week interval allows the first treatment to stimulate fibroblast activity before the second dose amplifies this response. Patients typically begin seeing improvements after the first session, with optimal results appearing 4-8 weeks after the second treatment.

Maintenance Phase: Sustaining Results

After completing the initial Profhilo injection protocol (two sessions), the practitioner should plan a maintenance schedule. The manufacturer’s recommendation and consensus clinical practice differ, so both are presented below.

Manufacturer (IBSA Instructions for Use):

  • Repeat the full treatment every 2 months
  • This is the schedule specified in the IFU supplied with the product

Consensus clinical practice:

  • Repeat the full two-session protocol every 6-9 months, adjusted to the individual patient’s response
  • Patients with rapid response or thinner skin may benefit from the shorter end of this range; patients with strong durable response may extend further
  • Clinical assessment at 6 months guides timing of the next cycle

Whichever cadence is selected, the practitioner should defer to the current IFU supplied with the product and document the rationale in the patient record.

Pro Tip

Use your practice management software to schedule maintenance appointments automatically. Setting up automated reminders at the 5-month mark increases rebooking rates by 60% compared to manual follow-up.

Dosage Precision

Each BAP point receives exactly 0.2ml of Profhilo. With 10 points total (5 per side), one 2ml syringe provides the complete treatment dose.

Practitioners should not increase the dose per point or add additional injection sites. The BAP technique's effectiveness relies on consistent dosing at anatomically correct locations.

Profhilo Injection Protocol: Correct Technique, Depth, and Safety

Following the standardised Profhilo injection protocol is critical for both patient safety and optimal clinical results. Profhilo must be deposited in the precise tissue plane to achieve proper diffusion.

Needle Specification

Use a 29G x 1/2″ (0.33 x 12mm) needle for all BAP injections. This is the needle specification supplied in the IBSA Profhilo package and offers several advantages:

  • Sufficient length to reach the deep dermis
  • Fine enough to minimise patient discomfort
  • Adequate flow rate for Profhilo's viscosity

Injection Depth: The Deep Dermis (Intradermal Placement)

Profhilo must be deposited intradermally, into the deep dermis. This aligns with the IBSA Instructions for Use, which classify Profhilo as a hyaluronic acid product for intradermal use, and with the published BAP safety literature (Beatini et al., PMC7327616), which describes BAP as an intradermal technique. A small visible wheal at each point is the expected sign of correct placement.

Depth landmarks:

  • Within the deep dermis, typically 2-4mm from the skin surface depending on regional skin thickness
  • Shallower than the subcutaneous fat compartment
  • A small wheal should be visible at the injection point – this is the expected sign of correct intradermal placement

Technique: Insert the needle at a shallow angle, advancing to approximately 2-4mm depth depending on regional skin thickness, so the bevel sits within the deep dermis. The product should flow with mild resistance characteristic of intradermal placement, and a small wheal should form at the point. If the needle passes too deep into the subcutaneous fat, the wheal will not form and diffusion will be suboptimal.

The Bolus Injection Technique

Profhilo is administered as a bolus (single depot) rather than a threading technique.

Procedure:

  1. Insert the needle to the correct depth
  2. Aspirate gently to confirm you're not in a vessel
  3. Inject the full 0.2ml slowly (over 10-15 seconds)
  4. Withdraw the needle whilst maintaining slight pressure with your non-dominant hand
  5. Do not massage the area

The bolus will be visible as a small raised bump immediately after injection. This is normal and expected. The product will begin diffusing within 24-48 hours.

Aspiration: A Critical Safety Step

Always aspirate before injecting Profhilo. Whilst the BAP points are in relatively safe zones, individual anatomy varies.

Aspiration technique:

  • Pull back gently on the plunger before injecting
  • Look for blood flashback in the syringe
  • If blood appears, withdraw the needle and reposition
  • Never inject if you see blood return

Vascular complications, whilst rare with the BAP technique, can be serious. Aspiration is your primary safety mechanism for avoiding intravascular injection.

For comprehensive guidance on obtaining proper consent before aesthetic procedures, review the requirements for digital consent forms to ensure full documentation of risks and benefits.

Post-Treatment Care and Clinical Management

Proper post-treatment guidance is essential for optimal results and patient satisfaction.

Managing the "Profhilo Bumps"

Patients will have visible raised areas (papules) at each injection point immediately after treatment. This is normal and indicates correct intradermal placement.

Patient instructions:

  • The bumps are temporary and will resolve within 24-48 hours
  • Do not massage or manipulate the treated areas
  • Avoid applying makeup for 6 hours post-treatment
  • The product will diffuse naturally through tissue planes

Some practitioners photograph the injection sites immediately after treatment to reassure patients that the appearance is expected.

Activity Restrictions

Advise patients to avoid the following for 24-48 hours post-treatment:

Heat exposure:

  • Saunas and steam rooms
  • Hot yoga or intense cardio
  • Direct sun exposure
  • Hot showers on the face

Physical activity:

  • Strenuous exercise
  • Heavy lifting
  • Activities causing excessive facial movement or sweating

Heat and increased blood flow can exacerbate swelling and may affect product distribution.

Documentation Best Practices

Comprehensive record-keeping protects both practitioner and patient. Modern aesthetic clinic software makes this documentation seamless.

Essential documentation:

  • Pre-treatment photographs (frontal, both lateral views)
  • Batch number and expiry date of product used
  • Injection points marked on a face map
  • Any adverse reactions or patient concerns
  • Post-treatment photographs at follow-up appointments

Using dedicated before and after photo tools integrated with patient records ensures consistent documentation and helps track treatment outcomes over time.

Signs Requiring Clinical Review

Instruct patients to contact the clinic immediately if they experience:

  • Severe pain at injection sites
  • Blanching or colour changes in the skin
  • Visual disturbances
  • Rapidly increasing swelling beyond the injection sites
  • Signs of infection (increasing redness, warmth, purulent discharge)

Whilst serious complications with the BAP technique are rare, early recognition and intervention are critical if they occur.

For clinics managing multiple practitioners and treatment protocols, robust patient records systems ensure every team member can access complete treatment history and respond appropriately to patient concerns.

Contraindications and Precautions

Profhilo should not be administered in the following circumstances. Practitioners must screen for these factors during consultation and document the assessment in the patient record.

  • Pregnancy and lactation – safety data is insufficient; treatment should be deferred
  • Active skin infection or inflammation at the treatment site – including active acne, herpes simplex outbreak, eczema, or dermatitis at any BAP point
  • Known hypersensitivity to hyaluronic acid or to any component of the formulation
  • Active autoimmune disease flare – including lupus, scleroderma, or other connective tissue disease in an active phase
  • Recent ablative laser or chemical peel within the previous 2 weeks at the treatment area
  • Concurrent anticoagulant therapy without medical clearance from the prescribing clinician, due to increased bruising and bleeding risk

Relative precautions, such as a history of keloid scarring, prior permanent filler in the treatment zone, or recent dental procedures, should be discussed during consultation and may warrant delay or modification of the protocol.

Profhilo vs Traditional HA Fillers

Practitioners often ask how Profhilo compares with traditional cross-linked hyaluronic acid dermal fillers. The two product classes differ in structure, mechanism, and intended use, and are best understood as complementary rather than substitutable.

Profhilo is fundamentally different from traditional hyaluronic acid dermal fillers in structure, mechanism, and application.

Key differences:

Aspect Profhilo Traditional HA Fillers
HA concentration 32mg/ml (64mg in a 2ml syringe – 32mg H-HA + 32mg L-HA) 20-24mg/ml (cross-linked)
Cross-linking Hybrid cooperative complex (no chemical cross-linking) Chemically cross-linked
Mechanism Bioremodelling (stimulates collagen and elastin) Volumising (fills and supports tissue)
Injection technique 10 BAP points, bolus injection Multiple points, variable technique
Primary indication Skin quality, laxity, hydration Volume loss, structural support
Diffusion Spreads through tissue planes Stays where placed

Profhilo treats skin quality from within by stimulating fibroblasts to produce new collagen and elastin. Fillers provide structural support and volume replacement. These are complementary treatments rather than alternatives.

Expert Picks

Expert Picks

Implementing digital treatment records? Learn how injection plotting tools power effective record-keeping in aesthetic practices.

Building your Profhilo protocol documentation? Discover Botox face mapping techniques you can adapt for bioremodelling treatments.

Managing multiple aesthetic treatment protocols? Compare the best aesthetic clinic software for standardising care across your practice.

Conclusion: Standardising Your MedSpa Protocols

The Profhilo BAP technique represents a paradigm shift in injectable skin treatments. By standardising the protocol around 10 precisely defined anatomical points, IBSA has created a treatment that is simultaneously more effective, safer, and faster than traditional skin booster approaches.

For aesthetic practitioners, mastering the Profhilo injection protocol requires:

  • Thorough understanding of facial anatomy and safe injection zones
  • Consistent adherence to the 0.2ml per point dosing protocol
  • Proper patient selection and realistic expectation setting
  • Meticulous documentation and follow-up scheduling

As bioremodelling treatments become increasingly popular, clinics that implement the standardised Profhilo injection protocol and comprehensive documentation systems will differentiate themselves through superior outcomes and patient safety.

Modern practice management systems help aesthetic clinics maintain protocol consistency across multiple practitioners, automate treatment scheduling, and provide the documentation infrastructure required for medical defence and regulatory compliance.

Ready to streamline your injectable treatment protocols? Book a demo to see how Pabau helps leading aesthetic clinics standardise care, reduce administrative burden, and scale with confidence.

Frequently Asked Questions

Can I use a cannula for Profhilo instead of a needle?

The BAP technique was developed for needle administration and IBSA’s clinical training materials specify a 29G x 1/2″ needle. The BAP points are designed as low-risk zones when correct needle technique is used, and the precise intradermal placement required for optimal diffusion is easier to achieve with a needle than a cannula. If a practitioner chooses to use a cannula, they should maintain the correct deep-dermal depth, deliver the full 0.2ml bolus at each defined BAP point, and have received appropriate cannula-technique training for bioremodelling products.

Can Profhilo be combined with botulinum toxin or dermal fillers?

Yes, but the timing matters. The accepted approach is to leave a 2-week interval between Profhilo and botulinum toxin in either direction. Profhilo and dermal fillers can be performed in the same session if different anatomical areas are treated, or with a 2-4 week interval between treatments in the same zone. The interval prevents the products from affecting each other’s placement, diffusion, or aesthetic outcome.

What are the most common side effects of the BAP technique?

Immediate, expected effects that resolve within 24-48 hours include visible papules at each injection point, mild tenderness, minor swelling, and small bruises. Less common effects (under 5% of patients) include moderate bruising, asymmetric swelling, and headache. Rare complications include infection (preventable with sterile technique), granuloma formation, allergic reaction to hyaluronic acid (extremely rare), and vascular compromise (avoidable with aspiration and correct placement at the defined BAP points).

How long do Profhilo results last?

After the initial two-session course, visible improvement in skin quality, hydration, and laxity typically persists for around 6 months in most patients, with continued collagen and elastin stimulation extending the underlying biological effect. The IBSA Instructions for Use specify maintenance every 2 months, while consensus clinical practice supports maintenance every 6-9 months adjusted to the individual patient’s response. Documenting each treatment date and the patient’s response guides the timing of the next cycle.

Is Profhilo safe during pregnancy or breastfeeding?

No. Profhilo is contraindicated during pregnancy and lactation because safety data in these populations is insufficient. Treatment should be deferred until after pregnancy and breastfeeding have concluded. Other absolute contraindications include known hypersensitivity to hyaluronic acid, active skin infection or inflammation at any BAP point, and an active autoimmune disease flare. Patients on anticoagulant therapy or who have recently had ablative laser or chemical peel treatment (within 2 weeks) require medical clearance or delay before proceeding.

×